APPLICATION
ANDA065336
TYPE
ANDA
ORIGINAL APPROVAL
2007-07-25
LATEST ACTION
2024-12-23
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
CEPHALEXINPrescription
CEPHALEXIN EQ 125MG BASE/5ML · FOR SUSPENSION · ORAL
CEPHALEXINPrescription
CEPHALEXIN EQ 250MG BASE/5ML · FOR SUSPENSION · ORAL
Approval history
2024-12-23Manufacturing (CMC) · Supplement 7 · unknownAP
2007-07-25OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.